Lonza started its operations in India in 1997 as a liaison office. The office was involved mainly into sourcing advance intermediates from India. Lonza came in as a full-fledged sales and commercial organization with the acquisition of Cambrex Bio Products in 2007 and was renamed as Lonza India Pvt. Ltd. in 2008.
Lonza India Pvt. Ltd. is a wholly owned subsidiary of Lonza Group. Lonza offers its full product portfolio in India and covers an entire cross section of the life sciences industry. The product offering consists of products for cell discovery, molecular biology, rapid testing tools, fine chemical intermediates and APIs and intermediates for agrochemicals, biocides for industrial application, disinfectants for hospitals and various performance chemicals. Our activities also include the sourcing of intermediates from strategic partners for our manufacturing plants worldwide.
Lonza continues to leverage its core strengths in innovation, technology, and regulatory expertise while capturing cross-divisional synergies in manufacturing, research, and sales. By clicking the Factsheet will find a detailed breakdown of our management committees, business divisions, group functions, key figures, and our sales by operating segments.
In Facts & Figures you will learn more about Lonza as well as our extraordinary team, awards, and successes.
Committed to Good Corporate Governance.
Lonza Group Ltd, a holding company under Swiss law, is fully committed to good corporate governance.Our governance is measured against the SIX Swiss Exchange’s “Directive on Information relating to Corporate Governance and the Swiss Code of Best Practice for Corporate Governance.” The Board of Directors reviews these principles and rules regularly to adhere to best practices. In March 2009, Lonza joined the United Nations Global Compact, a strategic policy initiative for businesses.